Skip to content
healthcare.dev
Get a free key

Zavesca

NDC 66215-201, miglustat, capsule, from Actelion Pharmaceuticals US, Inc..

Product NDC
66215-201
Status
Listed
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021348
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66215-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIGLUSTAT100 mg/1

Pharmacologic classes

Glucosylceramide Synthase Inhibitor [EPC]; Glucosylceramide Synthase Inhibitors [MoA]

Package NDCNDC-11Package
66215-201-90662150201906 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/817892d1-ee12-4632-85fc-57ccdf16d7b8

Use it

Look up 66215-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66215-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66215-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.